Utilizing Consumer Health Informatics to Support Management of Hypertension by Clinical Pharmacists in Primary Care

University of Michigan

Status: Completed

Conditions: Hypertension

Treatments: Other: BP Track

Study type: Interventional

Funder types: Other

Identifiers

NCT02898584

HUM00105772 (Other Identifier)

MICHR T3-RIP

Details and patient eligibility

About

The purpose of this research study is to test the feasibility, acceptability, and preliminary effectiveness of the use of a mobile pharmacist-led intervention that incorporates home BP monitoring and medication reminders with patients recruited from a primary care setting, as well as identify challenges and potential solutions to broader implementation of a mobile pharmacist-led home-based BP monitoring intervention in primary care clinics through key stakeholder interviews.

Enrollment: 16 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have a smart phone compatible with mobile intervention
• Have been previously diagnosed with hypertension
• Have uncontrolled hypertension (systolic blood pressure > 140 and/or diastolic blood pressure > 90 on repeat measurement)
• Be under the care of a primary care physician at the recruitment clinic
• Be taking at least one antihypertensive medication
• Be English speaking

Exclusion criteria

• Patients under the care of a clinical pharmacist for hypertension management, or under the care of a cardiologist
• Pregnant patients and anyone with the following unrelated, but serious medical conditions will also be excluded, as they may make blood pressure control difficult or necessitate frequent hospitalization: previous diagnosis of resistant hypertension; steroid dependent asthma or emphysema; cirrhosis or hepatic failure; stage C or D chronic heart failure; stage IV or V chronic kidney disease; and cancer (terminal or undergoing active chemotherapeutic or radiation therapy)
• Patients with other serious medical conditions (e.g., stroke, dementia) that may affect their ability to self-monitor blood pressure

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

16 participants in 1 patient group

BP Track

Other group

Description:

The study participants will be asked to monitor their blood pressure twice daily at home for twelve weeks, and sync the data to the mobile intervention so that a clinical pharmacist can review and incorporate the data into ongoing hypertension management.

Treatment:

Other: BP Track